Misuse of Artemisinin Combination Therapies by Clients of Medicine Retailers Suspected to Have Malaria Without Prior Parasitological Confirmation in Nigeria

Document Type: Original Article

Authors

1 Society for Family Health, Abuja, Nigeria

2 ANDI Centre of Excellence for Malaria Diagnosis, College of Medicine, University of Lagos, Lagos, Nigeria

Abstract

Background
Prompt and effective case detection and treatment are vital components of the malaria case management strategy as malaria-endemic countries implement the testing, treating and tracking policy. The implementation of this policy in public and formal private sectors continue to receive great attention while the informal private retail sector (mostly the patent and propriety medicine vendors [PPMVs]) where about 60% of patients with fever in Nigeria seek treatment is yet to be fully integrated. The PPMVs sell artemisinin combination therapies (ACTs) without prior testing and are highly patronized. Without prior testing, malaria is likely to be over-treated. The need to expand access to diagnosis in the huge informal private health sector among PPMVs is currently being explored to ensure that clients that patronize retail drug stores are tested before sales of ACTs.

 
Methods
A cross-sectional multistage study was conducted among 1279 adult clients, 20 years and above, who purchased malaria medicines from 119 selected PPMVs in five administrative areas (States) of Nigeria, namely: Adamawa, Cross River, Enugu, Lagos and Kaduna, as well as the Federal Capital Territory, Abuja. Exit interviews using a standard case report questionnaire was conducted after the purchase of the antimalarial medicine and thick/thin blood smears from the clients’ finger-prick were prepared to confirm malaria by expert microscopy.

 
Results
Of the 1279 clients who purchased malaria medicines from the PPMV outlets, 107 (8.4%) were confirmed to have malaria parasites. The malaria prevalence in the various study areas ranged from 3.5% to 16%. A high proportion of clients in the various study sites who had no need for malaria medicines (84%-96.5%) purchased and used antimalarial medicines from the PPMVs. This indicated a high level of over-treatment and misuse of antimalarials. Common symptoms that are widely used as indicators for malaria such as, fever, headache, and tiredness were not significantly associated with malaria. Nausea/vomiting, poor appetite, chills, bitter taste in the mouth and dark urine were symptoms that were significantly associated with malaria among the adult clients (P < .05) but not fever (P = .06).

 
Conclusion
Misuse of ACTs following overtreatment of malaria based on clinical diagnosis occurs when suspected cases of malaria are not prior confirmed with a test. Non-testing before sales of malaria medicines by PPMVs will perpetuate ACT misuse with the patients not benefiting due to poor treatment outcomes, waste of medicines and financial loss from out-of-pocket payment for unneeded medicines.

Keywords

Main Subjects


  1. FMOH. National Antimalarial Diagnosis and Treatment Policy, Abuja. Federal Ministry of     Health, National Malaria and Vector Control Division, Federal Republic of Nigeria; 2010.
  2. Oladosu OO, Oyibo WA. Overdiagnosis and Overtreatment of Malaria in Children that presented with fever in Lagos, Nigeria. ISRN Infect Dis. 2013;2013:6. doi:10.5402/2013/914675
  3. WHO. Guideline for the Treatment of Malaria. 2nd ed. Geneva: World Health Organization; 2010.
  4. FMOH. National Antimalarial Diagnosis and Treatment Guideline, Abuja. Federal Ministry of Health, National Malaria and Vector Control Division, Federal Republic of Nigeria; 2011.
  5. Chandler CI, Jones C, Boniface G, Juma K, Reyburn H, Whitty CJ. Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Malar J. 2008;7:53. doi:10.1186/1475-2875-7-53
  6. Reyburn H, Mbatia R, Drakeley C, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ. 2004;329(7476):1212. doi:10.1136/bmj.38251.658229.55
  7. Leslie T, Mikhail A, Mayan I, et al. Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study. BMJ. 2012;345:e4389. doi:10.1136/bmj.e4389
  8. Orish VN, Ansong JY, Onyeabor OS, Sanyaolu AO, Oyibo WA, Iriemenam NC. Overdiagnosis and overtreatment of malaria in children in a secondary healthcare centre in Sekondi-Takoradi, Ghana. Trop Doct. 2016;46(4):191-198. doi:10.1177/0049475515622861
  9. NPC. Nigeria Malaria Indicator Survey 2010 Report. National Population Commission (NPC) [Nigeria], National Malaria Control Programme (NMCP) and ICF International. Abuja, Nigeria; 2012.
  10. Mbonye AK, Ndyomugyenyi R, Turinde A, Magnussen P, Clarke S, Chandler C. The feasibility of introducing rapid diagnostic tests for malaria in drug shops in Uganda. Malar J. 2010;9:367. doi:10.1186/1475-2875-9-367
  11. Mbonye AK, Lal S, Cundill B, Hansen KS, Clarke S, Magnussen P. Treatment of fevers prior to introducing rapid diagnostic tests for malaria in registered drug shops in Uganda. Malar J. 2013;12:131. doi:10.1186/1475-2875-12-131
  12. Yeung S, Patouillard E, Allen H, Socheat D. Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia. Malar J. 2011;10:243. doi:10.1186/1475-2875-10-243
  13. Cohen J, Fink G, Berg K, et al. Feasibility of distributing rapid diagnostic tests for malaria in the retail sector: evidence from an implementation study in Uganda. PLoS One. 2012;7(11):e48296. doi:10.1371/journal.pone.0048296
  14. RBM. Diagnostic testing in retail private sector: lessons learned. Report of meeting of the RBM Case Management Working Group. London, UK; April 29-30, 2013.
  15. Rusk A, Goodman C, Naanyu V, Koech B, Obala A, O'Meara WP. Expanding access to malaria diagnosis through retail shops in Western Kenya: what do shop workers think? Malar Res Treat. 2013;2013:398143. doi:10.1155/2013/398143
  16. Patrick Kachur S, Schulden J, Goodman CA, et al. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Trop Med Int Health. 2006;11(4):441-451. doi:10.1111/j.1365-3156.2006.01588.x
  17. Briggs MA, Kalolella A, Bruxvoort K, et al. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies. PLoS One. 2014;9(4):e94074. doi:10.1371/journal.pone.0094074
  18. D'Acremont V, Lengeler C, Genton B. Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review. Malar J. 2010;9:240. doi:10.1186/1475-2875-9-240
  19. Ikwuobe JO, Faragher BE, Alawode G, Lalloo DG. The impact of rapid malaria diagnostic tests upon anti-malarial sales in community pharmacies in Gwagwalada, Nigeria. Malar J. 2013;12:380. doi:10.1186/1475-2875-12-380
  20. Kallander K, Nsungwa-Sabiiti J, Peterson S. Symptom overlap for malaria and pneumonia--policy implications for home management strategies. Acta Trop. 2004;90(2):211-214. doi:10.1016/j.actatropica.2003.11.013
  21. D'Acremont V, Kahama-Maro J, Swai N, Mtasiwa D, Genton B, Lengeler C. Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-after and cluster randomized controlled study. Malar J. 2011;10:107. doi:10.1186/1475-2875-10-107
  22. Yukich JO, Bennett A, Albertini A, et al. Reductions in artemisinin-based combination therapy consumption after the nationwide scale up of routine malaria rapid diagnostic testing in Zambia. Am J Trop Med Hyg. 2012;87(3):437-446. doi:10.4269/ajtmh.2012.12-0127
  23. Thiam S, Thior M, Faye B, et al. Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests. PLoS One. 2011;6(4):e18419. doi:10.1371/journal.pone.0018419